Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Ambev entered the second half of 2026 with favorable operating momentum: second-quarter organic net revenue increased 6.1%, normalized EBITDA increased 8.9%, and normalized EBITDA margin expanded to 31.6%, despite consolidated organic volume growth of only 1.4%. Brazil Beer was the principal strength, while Brazil NAB, Latin America South and Canada recorded volume declines. The issuer's analyst-coverage page lists 18 firms, with Neutral the modal recommendation (10 Neutral, 3 Buy and 5 Sell). A Hold view is therefore appropriate pending evidence that portfolio-led growth and margin expansion can persist beyond World Cup-related demand and brand investment.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets10 analysts · as of 18 Aug 2026
Low · most bearish analyst$2.60
Mean target$3.34
High · most bullish analyst$4.00
Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$2.6020%

Volume weakness broadens beyond Brazil NAB, Latin America South and Canada; price and mix no longer compensate for softer demand; and foreign-exchange, commodity, distribution and marketing costs reduce operating leverage. Normalized EBITDA growth falls below revenue growth and consolidated margin declines below 30%.

Base CaseCentral scenario
$3.3456%
Matches the consensus mean

Brazil Beer remains constructive but World Cup-related demand normalizes. Revenue management and portfolio mix continue offsetting modest consolidated volume growth, while weakness in Brazil NAB, Latin America South and Canada remains contained. Normalized EBITDA continues growing at least broadly with revenue.

Bull CaseUpside scenario
$4.0024%

Brazil Beer sustains volume and market-share momentum, premium and balanced-choice brands continue expanding, and digital channels improve execution. Revenue growth remains materially above volume growth while disciplined costs allow normalized EBITDA to outgrow revenue and preserve a margin above the second-quarter level.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Second-quarter organic net revenue growth of 6.1% exceeded organic volume growth of 1.4%, supported by 4.6% growth in net revenue per hectoliter.
  • Organic normalized EBITDA increased 8.9%, faster than revenue, and normalized EBITDA margin expanded by 80 basis points to 31.6%.
  • Brazil Beer delivered 5.0% organic volume growth and 12.8% organic normalized EBITDA growth, with the company reporting estimated market-share gains and strong premium-brand momentum.
Sign in / Sign up to read more
Key Investment Risks
  • Brazil NAB organic volumes declined 4.4% in the second quarter and continued to underperform the industry, notwithstanding positive revenue and EBITDA growth.
  • Organic volumes declined 2.9% in Latin America South and 1.8% in Canada, exposing results to regional demand, weather, social disruption and currency conditions.
  • Ambev retained full-year guidance for Brazil Beer cash COGS per hectoliter growth of 4.5% to 7.5%, indicating continuing foreign-exchange and commodity cost pressure.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.